×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Vulvar Cancer

Brielle Urciuoli
The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.
 
Kristie L. Kahl
The application is seeking approval for GARDASIL 9 to be used in women and men aged 27 to 45 years for the prevention of certain cancers and diseases caused by the nine human papillomavirus (HPV) types covered by the vaccine.
Katie Kosko
Women with vulvar cancer who test positive for human papillomavirus (HPV) may have improved survival compared with HPV-negative patients, according to the results of a new study.
Jason Harris
Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.
 
Wayne Kuznar
Treatment changes for the rare illness include less invasive surgery.
Christina Izzo
A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.
Beth Fand Incollingo
States with the highest incidence of, and mortality from, cervical cancer also have the lowest uptake of the human papillomavirus (HPV) vaccine by adolescent girls, researchers found in a recent study.
There are some things known to increase the risk of gynecologic cancers. Bottom line, being a woman puts you at risk.
Peter L. Saltonstall
NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer.
Charlotte Huff
Finding specialized care is worth the effort for patients with uncommon cancers.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other